Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy

• Status: Withdrawn
• Trial end date: 2015-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: TriHealth Inc.
• Treatments: Lidocaine; Ropivacaine

Criteria

Inclusion Criteria:

• Patients with breast lesions recommended for biopsy by physician

Exclusion Criteria:

• Patients with breast lesions not recommended for biopsy

• Patients with allergic reactions to lidocaine, ropivacaine, or related anesthetics